Full Text
The Full Text of this article is available as a PDF (123.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Evans William E., McLeod Howard L. Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med. 2003 Feb 6;348(6):538–549. doi: 10.1056/NEJMra020526. [DOI] [PubMed] [Google Scholar]
- Furuta T., Ohashi K., Kamata T., Takashima M., Kosuge K., Kawasaki T., Hanai H., Kubota T., Ishizaki T., Kaneko E. Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer. Ann Intern Med. 1998 Dec 15;129(12):1027–1030. doi: 10.7326/0003-4819-129-12-199812150-00006. [DOI] [PubMed] [Google Scholar]
- Krynetski E. Y., Tai H. L., Yates C. R., Fessing M. Y., Loennechen T., Schuetz J. D., Relling M. V., Evans W. E. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics. 1996 Aug;6(4):279–290. doi: 10.1097/00008571-199608000-00001. [DOI] [PubMed] [Google Scholar]
- Lima J. J., Thomason D. B., Mohamed M. H., Eberle L. V., Self T. H., Johnson J. A. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther. 1999 May;65(5):519–525. doi: 10.1016/S0009-9236(99)70071-8. [DOI] [PubMed] [Google Scholar]
- Roses A. D. Pharmacogenetics and the practice of medicine. Nature. 2000 Jun 15;405(6788):857–865. doi: 10.1038/35015728. [DOI] [PubMed] [Google Scholar]